We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

37 hedge funds and large institutions have $16.4M invested in Tempest Therapeutics in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $93K | Put options by funds: $48K

28% more capital invested

Capital invested by funds: $12.9M → $16.4M (+$3.57M)

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

12% less funds holding

Funds holding: 42 → 37 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
10
Reduced
9
Closed
11
Calls
$93K
Puts
$48K
Net Calls
+$45K
Net Calls Change
+$198K

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$642K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$232K
3
Two Sigma Investments
Two Sigma Investments
New York
+$157K
4
JP Morgan Chase
JP Morgan Chase
New York
+$132K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$99.9K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$1.61M
2
B
Bpifrance
France
-$875K
3
AIC
AWM Investment Company
New York
-$324K
4
WG
Winton Group
United Kingdom
-$189K
5
GC
GMT Capital
Georgia
-$87K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$40K +$691 +2 +2%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$31K +$6.91K +20 +38%
BFM
28
Boothbay Fund Management
New York
$30K – – –
Simplex Trading
29
Simplex Trading
Illinois
$28K -$691 -2 -3%
Citigroup
30
Citigroup
New York
$11K – – –
CG
31
Cutler Group
California
$10K – – –
TRCT
32
Tower Research Capital (TRC)
New York
$5K -$3.11K -9 -41%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$2.35K -$2.42K -7 -54%
Morgan Stanley
34
Morgan Stanley
New York
$2K – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$1K +$1.04K +3 New
RE
36
RBC Europe
United Kingdom
$13 – – –
B
37
Bpifrance
France
– -$875K -2,753 Closed
AIC
38
AWM Investment Company
New York
– -$324K -1,021 Closed
GC
39
GMT Capital
Georgia
– -$87K -272 Closed
Verition Fund Management
40
Verition Fund Management
Connecticut
– -$65K -205 Closed
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
– -$36K -112 Closed
WS
42
Wedbush Securities
California
– -$23K -74 Closed
Millennium Management
43
Millennium Management
New York
– -$22 -70 Closed
Bank of America
44
Bank of America
North Carolina
– -$14.9K -43 Closed
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
– -$3K -9 Closed
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
– -$2.42K -7 Closed
1
2

TPST Hedge Fund Activity: Q4 2020 in Review

37 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2020, worth a combined $16.4M — up 28% from $12.9M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of TPST and 6 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 10 added.

The largest buyer was Barclays, adding an estimated $642K. The largest seller was Great Point Partners, cutting an estimated $1.61M.

  • 37 institutional investors held Tempest Therapeutics (TPST) as of Q4 2020, down from 42 in Q3 2020.
  • Funds reported $16.4M of Tempest Therapeutics stock for Q4 2020, up 28% quarter-over-quarter.
  • 6 funds opened new Tempest Therapeutics positions in Q4 2020 and 11 closed out, a net change of -5 holders.
  • The largest Tempest Therapeutics buyer in Q4 2020 was Barclays, an estimated $642K added.
  • The largest Tempest Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $1.61M sold.

Based on aggregated 13F filings for Q4 2020.